Share Price and Basic Stock Data
Last Updated: November 10, 2025, 10:45 pm
| PEG Ratio | -1.36 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
UPL Ltd, a significant player in the agrochemicals and pesticides industry, reported a stock price of ₹702 and a market capitalization of ₹59,158 Cr. for the latest period. The company has shown robust growth in revenue, with sales rising from ₹46,240 Cr. in FY 2022 to ₹53,576 Cr. in FY 2023. However, FY 2024 saw a decline in sales to ₹43,098 Cr., followed by a recovery to ₹46,637 Cr. in FY 2025, indicating volatility in revenue generation. Quarterly sales figures also illustrate fluctuations, with the highest quarterly sales of ₹16,569 Cr. recorded in Q4 FY 2023, and a dip to ₹8,963 Cr. in Q1 FY 2024. This trend highlights the seasonal nature of the agrochemical market, influenced by factors such as agricultural cycles and weather conditions. The company’s operations are supported by a robust sales network, which is critical in a sector where timely product availability can significantly impact revenue.
Profitability and Efficiency Metrics
UPL Ltd’s profitability metrics reflect a mixed performance. The company’s operating profit margin (OPM) stood at 15% for FY 2025, a recovery from the low of 10% in FY 2024. However, the net profit margin saw a decline, with net profit recorded at ₹1,171 Cr. for FY 2025, following a loss of ₹1,878 Cr. in FY 2024. The return on equity (ROE) was reported at 3.29%, which is considerably lower than the typical sector average, indicating challenges in generating shareholder value. The interest coverage ratio (ICR) of 2.23x suggests that the company can cover its interest obligations, although it remains below optimal levels. UPL’s cash conversion cycle (CCC) of 112 days indicates that the company takes a considerable time to convert its investments in inventory and receivables into cash, which can strain liquidity during periods of low sales.
Balance Sheet Strength and Financial Ratios
UPL Ltd’s balance sheet reflects a combination of strengths and vulnerabilities. The company reported reserves of ₹29,054 Cr. against borrowings of ₹25,099 Cr., indicating a relatively healthy reserve-to-debt ratio. The total liabilities stood at ₹86,012 Cr., with total assets also matching this figure. The company’s long-term debt-to-equity ratio of 0.62x indicates moderate leverage, which is below the sector average, suggesting prudent financial management. However, the current ratio of 1.39x and quick ratio of 1.03x show that UPL is just above the ideal threshold for liquidity, which may raise concerns in times of financial distress. Furthermore, the price-to-book value (P/BV) ratio of 1.73x suggests that the stock is trading at a premium compared to its book value, which may reflect market optimism or overvaluation.
Shareholding Pattern and Investor Confidence
The shareholding pattern of UPL Ltd indicates a diverse ownership structure, with promoters holding 33.49% of the equity, while foreign institutional investors (FIIs) account for 37.01%. Domestic institutional investors (DIIs) hold 17.17%, and the public holds the remaining 12.33%. This distribution suggests a fair level of institutional confidence in the company, although a slight decline in FII shareholding from 38.69% in March 2023 to 34.22% in March 2025 may indicate caution among foreign investors. The total number of shareholders increased from 2,53,054 in December 2022 to 2,84,675 in March 2025, demonstrating growing retail interest. However, the declining percentage of public shareholders could imply that institutional investors are becoming dominant, which may affect the company’s governance dynamics and decision-making processes.
Outlook, Risks, and Final Insight
UPL Ltd faces a mixed outlook characterized by both opportunities and risks. The recovery in sales and profitability metrics signals potential for growth, especially with the company’s strategic initiatives in product development and market expansion. However, risks such as fluctuating commodity prices, regulatory changes in the agrochemical sector, and challenges in maintaining operating margins persist. The company’s reliance on domestic agricultural cycles makes it vulnerable to external factors such as climate change and global market volatility. Investors should remain cautious, as the ongoing fluctuations in financial performance may affect long-term stability. If UPL can effectively navigate these challenges and leverage its operational strengths, it has the potential to enhance shareholder value and improve its financial standing in the competitive agrochemical landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of UPL Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 6,576 Cr. | 1,528 | 2,243/1,497 | 16.4 | 487 | 0.39 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 806 Cr. | 239 | 391/165 | 15.4 | 117 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 52.8 Cr. | 101 | 148/55.2 | 9.65 | 34.1 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,181 Cr. | 246 | 365/228 | 120 | 54.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 735 Cr. | 311 | 670/244 | 10.7 | 320 | 0.96 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,441.05 Cr | 1,506.59 | 29.71 | 447.42 | 0.44% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,821 | 12,507 | 13,679 | 16,569 | 8,963 | 10,170 | 9,887 | 14,078 | 9,067 | 11,090 | 10,907 | 15,573 | 9,216 |
| Expenses | 8,675 | 10,090 | 10,795 | 13,847 | 7,747 | 9,049 | 9,820 | 12,230 | 7,998 | 9,873 | 9,229 | 12,409 | 7,820 |
| Operating Profit | 2,146 | 2,417 | 2,884 | 2,722 | 1,216 | 1,121 | 67 | 1,848 | 1,069 | 1,217 | 1,678 | 3,164 | 1,396 |
| OPM % | 20% | 19% | 21% | 16% | 14% | 11% | 1% | 13% | 12% | 11% | 15% | 20% | 15% |
| Other Income | 25 | 35 | 129 | 302 | 58 | 18 | 134 | 66 | 49 | 103 | 94 | -168 | 152 |
| Interest | 519 | 644 | 894 | 906 | 700 | 871 | 1,191 | 1,090 | 913 | 1,070 | 730 | 914 | 1,007 |
| Depreciation | 588 | 608 | 624 | 727 | 636 | 657 | 676 | 794 | 660 | 697 | 688 | 705 | 731 |
| Profit before tax | 1,064 | 1,200 | 1,495 | 1,391 | -62 | -389 | -1,666 | 30 | -455 | -447 | 354 | 1,377 | -190 |
| Tax % | 6% | 19% | 9% | 22% | -265% | -25% | -4% | 367% | 16% | 31% | -141% | 22% | -7% |
| Net Profit | 1,005 | 969 | 1,360 | 1,080 | 102 | -293 | -1,607 | -80 | -527 | -585 | 853 | 1,079 | -176 |
| EPS in Rs | 10.39 | 9.64 | 12.87 | 9.38 | 1.97 | -2.24 | -14.41 | 0.47 | -4.55 | -5.25 | 9.81 | 10.61 | -1.04 |
Last Updated: August 20, 2025, 1:45 am
Below is a detailed analysis of the quarterly data for UPL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 9,216.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15,573.00 Cr. (Mar 2025) to 9,216.00 Cr., marking a decrease of 6,357.00 Cr..
- For Expenses, as of Jun 2025, the value is 7,820.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12,409.00 Cr. (Mar 2025) to 7,820.00 Cr., marking a decrease of 4,589.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 1,396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,164.00 Cr. (Mar 2025) to 1,396.00 Cr., marking a decrease of 1,768.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Mar 2025) to 15.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 152.00 Cr.. The value appears strong and on an upward trend. It has increased from -168.00 Cr. (Mar 2025) to 152.00 Cr., marking an increase of 320.00 Cr..
- For Interest, as of Jun 2025, the value is 1,007.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 914.00 Cr. (Mar 2025) to 1,007.00 Cr., marking an increase of 93.00 Cr..
- For Depreciation, as of Jun 2025, the value is 731.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 705.00 Cr. (Mar 2025) to 731.00 Cr., marking an increase of 26.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -190.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,377.00 Cr. (Mar 2025) to -190.00 Cr., marking a decrease of 1,567.00 Cr..
- For Tax %, as of Jun 2025, the value is -7.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Mar 2025) to -7.00%, marking a decrease of 29.00%.
- For Net Profit, as of Jun 2025, the value is -176.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,079.00 Cr. (Mar 2025) to -176.00 Cr., marking a decrease of 1,255.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.04. The value appears to be declining and may need further review. It has decreased from 10.61 (Mar 2025) to -1.04, marking a decrease of 11.65.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:12 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10,771 | 12,091 | 14,048 | 16,312 | 17,378 | 21,837 | 35,756 | 38,694 | 46,240 | 53,576 | 43,098 | 46,637 | 46,786 |
| Expenses | 8,753 | 9,728 | 11,700 | 13,346 | 13,966 | 18,024 | 28,984 | 30,342 | 36,711 | 43,380 | 38,801 | 39,509 | 39,331 |
| Operating Profit | 2,018 | 2,363 | 2,348 | 2,966 | 3,412 | 3,813 | 6,772 | 8,352 | 9,529 | 10,196 | 4,297 | 7,128 | 7,455 |
| OPM % | 19% | 20% | 17% | 18% | 20% | 17% | 19% | 22% | 21% | 19% | 10% | 15% | 16% |
| Other Income | 30 | -11 | 149 | 363 | 351 | -197 | -515 | 62 | 91 | 464 | 231 | 78 | 181 |
| Interest | 485 | 517 | 704 | 735 | 783 | 963 | 1,481 | 2,060 | 2,295 | 2,963 | 3,852 | 3,627 | 3,721 |
| Depreciation | 407 | 425 | 676 | 672 | 675 | 880 | 2,012 | 2,173 | 2,359 | 2,547 | 2,763 | 2,750 | 2,821 |
| Profit before tax | 1,157 | 1,410 | 1,117 | 1,922 | 2,305 | 1,773 | 2,764 | 4,181 | 4,966 | 5,150 | -2,087 | 829 | 1,094 |
| Tax % | 19% | 17% | 15% | 10% | 12% | 11% | 21% | 16% | 11% | 14% | -10% | 1% | |
| Net Profit | 957 | 1,187 | 952 | 1,733 | 2,030 | 1,575 | 2,178 | 3,495 | 4,437 | 4,414 | -1,878 | 820 | 1,171 |
| EPS in Rs | 13.13 | 15.82 | 13.00 | 20.18 | 23.57 | 17.35 | 20.66 | 33.40 | 42.18 | 42.28 | -14.21 | 10.62 | 14.13 |
| Dividend Payout % | 18% | 19% | 23% | 20% | 20% | 27% | 26% | 27% | 21% | 21% | -6% | 53% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 24.03% | -19.80% | 82.04% | 17.14% | -22.41% | 38.29% | 60.47% | 26.95% | -0.52% | -142.55% | 143.66% |
| Change in YoY Net Profit Growth (%) | 0.00% | -43.83% | 101.84% | -64.90% | -39.55% | 60.70% | 22.18% | -33.52% | -27.47% | -142.03% | 286.21% |
UPL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 5% |
| 3 Years: | 0% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -16% |
| 3 Years: | -38% |
| TTM: | 182% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | -1% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 4% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:50 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109 | 115 | 133 | 127 | 127 | 195 | 121 | 115 | 121 | 124 | 138 | 121 |
| Inventory Days | 166 | 178 | 204 | 194 | 204 | 306 | 153 | 180 | 216 | 187 | 198 | 167 |
| Days Payable | 181 | 195 | 213 | 228 | 255 | 330 | 199 | 244 | 274 | 236 | 196 | 176 |
| Cash Conversion Cycle | 95 | 98 | 124 | 93 | 76 | 171 | 75 | 51 | 64 | 76 | 141 | 112 |
| Working Capital Days | 64 | 45 | 48 | 84 | 94 | 127 | 59 | 52 | 38 | 46 | 52 | 9 |
| ROCE % | 19% | 21% | 19% | 22% | 21% | 10% | 10% | 13% | 14% | 14% | 3% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Nifty 50 ETF | 9,105,577 | 0.28 | 489.61 | 9,105,577 | 2025-04-22 17:25:16 | 0% |
| UTI Nifty 50 ETF | 2,521,527 | 0.28 | 135.58 | 2,521,527 | 2025-04-22 17:25:16 | 0% |
| SBI Arbitrage Opportunities Fund | 1,292,200 | 0.26 | 69.48 | 1,292,200 | 2025-04-22 17:25:16 | 0% |
| Nippon India ETF Nifty 50 BeES | 1,075,205 | 0.28 | 57.81 | 1,075,205 | 2025-04-22 09:14:30 | 0% |
| UTI Nifty 50 Index Fund | 810,001 | 0.28 | 43.55 | 810,001 | 2025-04-22 17:25:16 | 0% |
| DSP Nifty 50 Equal Weight Index Fund | 341,976 | 1.79 | 18.39 | 341,976 | 2025-04-22 17:25:16 | 0% |
| SBI Nifty Index Fund | 327,375 | 0.29 | 17.6 | 327,375 | 2025-04-22 17:25:16 | 0% |
| SBI Nifty50 Equal Weight Index Fund | 290,494 | 1.73 | 15.62 | 290,494 | 2025-04-22 17:25:16 | 0% |
| Nippon India Arbitrage Fund | 215,800 | 0.09 | 11.6 | 215,800 | 2025-04-22 17:25:16 | 0% |
| Invesco India Arbitrage Fund | 163,800 | 0.08 | 9.62 | 163,800 | 2025-04-22 17:25:16 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 9.85 | -17.80 | 45.79 | 45.87 | 36.40 |
| Diluted EPS (Rs.) | 9.62 | -17.80 | 45.79 | 45.87 | 36.40 |
| Cash EPS (Rs.) | 50.84 | 15.03 | 90.72 | 87.08 | 73.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 367.46 | 330.76 | 432.57 | 344.08 | 282.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 367.46 | 330.76 | 432.57 | 344.08 | 282.27 |
| Revenue From Operations / Share (Rs.) | 586.63 | 574.64 | 714.35 | 604.44 | 505.80 |
| PBDIT / Share (Rs.) | 101.71 | 66.96 | 142.31 | 128.24 | 112.55 |
| PBIT / Share (Rs.) | 67.12 | 30.12 | 108.35 | 97.40 | 84.14 |
| PBT / Share (Rs.) | 16.36 | -24.60 | 66.57 | 63.16 | 54.10 |
| Net Profit / Share (Rs.) | 16.25 | -21.81 | 56.76 | 56.25 | 45.14 |
| NP After MI And SOA / Share (Rs.) | 11.28 | -16.00 | 47.60 | 47.40 | 37.53 |
| PBDIT Margin (%) | 17.33 | 11.65 | 19.92 | 21.21 | 22.25 |
| PBIT Margin (%) | 11.44 | 5.24 | 15.16 | 16.11 | 16.63 |
| PBT Margin (%) | 2.78 | -4.28 | 9.31 | 10.44 | 10.69 |
| Net Profit Margin (%) | 2.77 | -3.79 | 7.94 | 9.30 | 8.92 |
| NP After MI And SOA Margin (%) | 1.92 | -2.78 | 6.66 | 7.84 | 7.41 |
| Return on Networth / Equity (%) | 3.07 | -4.83 | 13.29 | 16.72 | 16.03 |
| Return on Capital Employeed (%) | 8.97 | 3.72 | 13.64 | 13.67 | 12.67 |
| Return On Assets (%) | 1.01 | -1.37 | 4.03 | 4.38 | 4.07 |
| Long Term Debt / Equity (X) | 0.62 | 0.96 | 0.75 | 0.99 | 1.24 |
| Total Debt / Equity (X) | 0.81 | 1.15 | 0.85 | 1.19 | 1.32 |
| Asset Turnover Ratio (%) | 0.53 | 0.48 | 0.37 | 0.36 | 0.26 |
| Current Ratio (X) | 1.39 | 1.46 | 1.45 | 1.41 | 1.53 |
| Quick Ratio (X) | 1.03 | 0.98 | 0.96 | 0.94 | 1.05 |
| Inventory Turnover Ratio (X) | 1.58 | 1.43 | 1.45 | 1.41 | 1.15 |
| Dividend Payout Ratio (NP) (%) | 8.36 | -62.41 | 21.03 | 21.07 | 15.95 |
| Dividend Payout Ratio (CP) (%) | 2.05 | 47.92 | 12.27 | 12.76 | 9.08 |
| Earning Retention Ratio (%) | 91.64 | 162.41 | 78.97 | 78.93 | 84.05 |
| Cash Earning Retention Ratio (%) | 97.95 | 52.08 | 87.73 | 87.24 | 90.92 |
| Interest Coverage Ratio (X) | 2.23 | 1.30 | 3.60 | 4.27 | 4.18 |
| Interest Coverage Ratio (Post Tax) (X) | 1.47 | 0.64 | 2.49 | 3.02 | 2.79 |
| Enterprise Value (Cr.) | 70381.90 | 61503.75 | 76295.75 | 83275.05 | 71528.30 |
| EV / Net Operating Revenue (X) | 1.51 | 1.43 | 1.42 | 1.80 | 1.85 |
| EV / EBITDA (X) | 8.70 | 12.25 | 7.15 | 8.49 | 8.31 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
| Retention Ratios (%) | 91.63 | 162.41 | 78.96 | 78.92 | 84.04 |
| Price / BV (X) | 1.73 | 1.38 | 2.00 | 2.72 | 2.74 |
| Price / Net Operating Revenue (X) | 1.08 | 0.79 | 1.00 | 1.27 | 1.27 |
| EarningsYield | 0.01 | -0.03 | 0.06 | 0.06 | 0.05 |
After reviewing the key financial ratios for UPL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.85, marking an increase of 27.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 9.62. This value is within the healthy range. It has increased from -17.80 (Mar 24) to 9.62, marking an increase of 27.42.
- For Cash EPS (Rs.), as of Mar 25, the value is 50.84. This value is within the healthy range. It has increased from 15.03 (Mar 24) to 50.84, marking an increase of 35.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has increased from 330.76 (Mar 24) to 367.46, marking an increase of 36.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 367.46. It has increased from 330.76 (Mar 24) to 367.46, marking an increase of 36.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 586.63. It has increased from 574.64 (Mar 24) to 586.63, marking an increase of 11.99.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 101.71. This value is within the healthy range. It has increased from 66.96 (Mar 24) to 101.71, marking an increase of 34.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is 67.12. This value is within the healthy range. It has increased from 30.12 (Mar 24) to 67.12, marking an increase of 37.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.36. This value is within the healthy range. It has increased from -24.60 (Mar 24) to 16.36, marking an increase of 40.96.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.25. This value is within the healthy range. It has increased from -21.81 (Mar 24) to 16.25, marking an increase of 38.06.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.28. This value is within the healthy range. It has increased from -16.00 (Mar 24) to 11.28, marking an increase of 27.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 17.33, marking an increase of 5.68.
- For PBIT Margin (%), as of Mar 25, the value is 11.44. This value is within the healthy range. It has increased from 5.24 (Mar 24) to 11.44, marking an increase of 6.20.
- For PBT Margin (%), as of Mar 25, the value is 2.78. This value is below the healthy minimum of 10. It has increased from -4.28 (Mar 24) to 2.78, marking an increase of 7.06.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from -3.79 (Mar 24) to 2.77, marking an increase of 6.56.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 8. It has increased from -2.78 (Mar 24) to 1.92, marking an increase of 4.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.07. This value is below the healthy minimum of 15. It has increased from -4.83 (Mar 24) to 3.07, marking an increase of 7.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. It has increased from 3.72 (Mar 24) to 8.97, marking an increase of 5.25.
- For Return On Assets (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 5. It has increased from -1.37 (Mar 24) to 1.01, marking an increase of 2.38.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.62. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.62, marking a decrease of 0.34.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.81. This value is within the healthy range. It has decreased from 1.15 (Mar 24) to 0.81, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.53. It has increased from 0.48 (Mar 24) to 0.53, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.03, marking an increase of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.58. This value is below the healthy minimum of 4. It has increased from 1.43 (Mar 24) to 1.58, marking an increase of 0.15.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.36. This value is below the healthy minimum of 20. It has increased from -62.41 (Mar 24) to 8.36, marking an increase of 70.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 20. It has decreased from 47.92 (Mar 24) to 2.05, marking a decrease of 45.87.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.64. This value exceeds the healthy maximum of 70. It has decreased from 162.41 (Mar 24) to 91.64, marking a decrease of 70.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.95. This value exceeds the healthy maximum of 70. It has increased from 52.08 (Mar 24) to 97.95, marking an increase of 45.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.23. This value is below the healthy minimum of 3. It has increased from 1.30 (Mar 24) to 2.23, marking an increase of 0.93.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 3. It has increased from 0.64 (Mar 24) to 1.47, marking an increase of 0.83.
- For Enterprise Value (Cr.), as of Mar 25, the value is 70,381.90. It has increased from 61,503.75 (Mar 24) to 70,381.90, marking an increase of 8,878.15.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has increased from 1.43 (Mar 24) to 1.51, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 8.70. This value is within the healthy range. It has decreased from 12.25 (Mar 24) to 8.70, marking a decrease of 3.55.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For Retention Ratios (%), as of Mar 25, the value is 91.63. This value exceeds the healthy maximum of 70. It has decreased from 162.41 (Mar 24) to 91.63, marking a decrease of 70.78.
- For Price / BV (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 1.73, marking an increase of 0.35.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.08, marking an increase of 0.29.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.03 (Mar 24) to 0.01, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UPL Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.97% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.07% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.47
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.03
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.7 (Industry average Stock P/E: 23.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.81
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%